ClinicalTrialsFinder
RecruitingNot ApplicableNCT06903676

Utility of Trypsinogen -2 in Early Detection and Follow Up of Post-pancreatectomy Acute Pancreatitis (PPAP)

Sponsor

Indiana University

Enrollment

50 participants

Start Date

Aug 5, 2025

Study Type

INTERVENTIONAL

Conditions

PancreatitisPancreatectomy

Summary

The goal of this study is to learn if urine trypsinogen can be used to diagnose post-pancreatectomy acute pancreatitis in patients undergoing pancreatectomy. Participants will have their urine measured by dipsticks during and after their surgery.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called TRP-2 Urine Dipstick for people with pancreatectomy and pancreatitis. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETRP-2 Urine Dipstick

Urine dipstick testing for Trypsinogen-2

Locations(1)

Indiana University Health University Hospital

Indianapolis, Indiana, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06903676

Related Trials

Hybrid Closed-Loop Insulin Delivery After Pancreatectomy

NCT074302932 locations

Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes

NCT069677011 location

A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma

NCT0333470813 locations

Phosphate in Acute Pancreatitis

NCT076810501 location

Internet-Delivered Pain Self-Management for Persons With Acute Recurrent and Chronic Pancreatitis Pain

NCT063862241 location